Loading…

Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase

We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assay...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2006-07, Vol.49 (14), p.4183-4195
Main Authors: NGUYEN, Corinne, RUDA, Gian Filippo, SCHIPANI, Alessandro, KASINATHAN, Ganasan, LEAL, Isabel, MUSSO-BUENDIA, Alexander, KAISER, Marcel, BRUN, Reto, RUIZ-PéREZ, Luis M., SAHLBERG, Britt-Louise, JOHANSSON, Nils Gunnar, GONZáLEZ-PACANOWSKA, Dolores, GILBERT, Ian H.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 4195
container_issue 14
container_start_page 4183
container_title Journal of medicinal chemistry
container_volume 49
creator NGUYEN, Corinne
RUDA, Gian Filippo
SCHIPANI, Alessandro
KASINATHAN, Ganasan
LEAL, Isabel
MUSSO-BUENDIA, Alexander
KAISER, Marcel
BRUN, Reto
RUIZ-PéREZ, Luis M.
SAHLBERG, Britt-Louise
JOHANSSON, Nils Gunnar
GONZáLEZ-PACANOWSKA, Dolores
GILBERT, Ian H.
description We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.
doi_str_mv 10.1021/jm060126s
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68608803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68608803</sourcerecordid><originalsourceid>FETCH-LOGICAL-i277t-45c465835ca3398dff711bf6e9473bc58e96e8053a70ed6f25b71476e590a6653</originalsourceid><addsrcrecordid>eNpFzztPwzAQAGALgWgpDPwBlAW2wPntjKXiUbWCCtqFJXIcB1ycpMSJRP89kVpgutPdp3sgdI7hGgPBN-sSBGAiwgEaYk4gZgrYIRoCEBITQegAnYSwBgCKCT1GAywUwVKqIZqNzdZ4Z6KnznhbB5fbaFxpX793NkQ6RNPqw2WurZsQ1UW08DqUde66Miq0N26jmz7NV8uFDvYUHfXFYM_2cYRW93fLyWM8f36YTsbz2BEp25hxwwRXlBtNaaLyopAYZ4WwCZM0M1zZRFgFnGoJNhcF4ZnETArLE9BCcDpCV7u5m6b-6s9s09IFY73Xla27kAolQCmgPbzYwy4rbZ5uGlfqZpv-vt-Dyz3QwWhfNLoyLvw7mVAGTPQu3jkXWvv919fNZyoklTxdLl77tXj2Nnu5TYH-AHtydnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68608803</pqid></control><display><type>article</type><title>Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>NGUYEN, Corinne ; RUDA, Gian Filippo ; SCHIPANI, Alessandro ; KASINATHAN, Ganasan ; LEAL, Isabel ; MUSSO-BUENDIA, Alexander ; KAISER, Marcel ; BRUN, Reto ; RUIZ-PéREZ, Luis M. ; SAHLBERG, Britt-Louise ; JOHANSSON, Nils Gunnar ; GONZáLEZ-PACANOWSKA, Dolores ; GILBERT, Ian H.</creator><creatorcontrib>NGUYEN, Corinne ; RUDA, Gian Filippo ; SCHIPANI, Alessandro ; KASINATHAN, Ganasan ; LEAL, Isabel ; MUSSO-BUENDIA, Alexander ; KAISER, Marcel ; BRUN, Reto ; RUIZ-PéREZ, Luis M. ; SAHLBERG, Britt-Louise ; JOHANSSON, Nils Gunnar ; GONZáLEZ-PACANOWSKA, Dolores ; GILBERT, Ian H.</creatorcontrib><description>We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm060126s</identifier><identifier>PMID: 16821778</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials - chemical synthesis ; Antimalarials - pharmacology ; Antiparasitic agents ; Biological and medical sciences ; Erythrocytes - drug effects ; Erythrocytes - parasitology ; Humans ; In Vitro Techniques ; Medical sciences ; Models, Molecular ; Nucleosides - chemical synthesis ; Nucleosides - pharmacology ; Pharmacology. Drug treatments ; Plasmodium falciparum - drug effects ; Plasmodium falciparum - enzymology ; Pyrophosphatases - antagonists &amp; inhibitors ; Pyrophosphatases - chemistry ; Stereoisomerism ; Structure-Activity Relationship ; Trityl Compounds - chemical synthesis ; Trityl Compounds - pharmacology ; Uracil - analogs &amp; derivatives ; Uracil - chemical synthesis ; Uracil - pharmacology</subject><ispartof>Journal of medicinal chemistry, 2006-07, Vol.49 (14), p.4183-4195</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17934046$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16821778$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NGUYEN, Corinne</creatorcontrib><creatorcontrib>RUDA, Gian Filippo</creatorcontrib><creatorcontrib>SCHIPANI, Alessandro</creatorcontrib><creatorcontrib>KASINATHAN, Ganasan</creatorcontrib><creatorcontrib>LEAL, Isabel</creatorcontrib><creatorcontrib>MUSSO-BUENDIA, Alexander</creatorcontrib><creatorcontrib>KAISER, Marcel</creatorcontrib><creatorcontrib>BRUN, Reto</creatorcontrib><creatorcontrib>RUIZ-PéREZ, Luis M.</creatorcontrib><creatorcontrib>SAHLBERG, Britt-Louise</creatorcontrib><creatorcontrib>JOHANSSON, Nils Gunnar</creatorcontrib><creatorcontrib>GONZáLEZ-PACANOWSKA, Dolores</creatorcontrib><creatorcontrib>GILBERT, Ian H.</creatorcontrib><title>Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.</description><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials - chemical synthesis</subject><subject>Antimalarials - pharmacology</subject><subject>Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Erythrocytes - drug effects</subject><subject>Erythrocytes - parasitology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Nucleosides - chemical synthesis</subject><subject>Nucleosides - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasmodium falciparum - drug effects</subject><subject>Plasmodium falciparum - enzymology</subject><subject>Pyrophosphatases - antagonists &amp; inhibitors</subject><subject>Pyrophosphatases - chemistry</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Trityl Compounds - chemical synthesis</subject><subject>Trityl Compounds - pharmacology</subject><subject>Uracil - analogs &amp; derivatives</subject><subject>Uracil - chemical synthesis</subject><subject>Uracil - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpFzztPwzAQAGALgWgpDPwBlAW2wPntjKXiUbWCCtqFJXIcB1ycpMSJRP89kVpgutPdp3sgdI7hGgPBN-sSBGAiwgEaYk4gZgrYIRoCEBITQegAnYSwBgCKCT1GAywUwVKqIZqNzdZ4Z6KnznhbB5fbaFxpX793NkQ6RNPqw2WurZsQ1UW08DqUde66Miq0N26jmz7NV8uFDvYUHfXFYM_2cYRW93fLyWM8f36YTsbz2BEp25hxwwRXlBtNaaLyopAYZ4WwCZM0M1zZRFgFnGoJNhcF4ZnETArLE9BCcDpCV7u5m6b-6s9s09IFY73Xla27kAolQCmgPbzYwy4rbZ5uGlfqZpv-vt-Dyz3QwWhfNLoyLvw7mVAGTPQu3jkXWvv919fNZyoklTxdLl77tXj2Nnu5TYH-AHtydnA</recordid><startdate>20060713</startdate><enddate>20060713</enddate><creator>NGUYEN, Corinne</creator><creator>RUDA, Gian Filippo</creator><creator>SCHIPANI, Alessandro</creator><creator>KASINATHAN, Ganasan</creator><creator>LEAL, Isabel</creator><creator>MUSSO-BUENDIA, Alexander</creator><creator>KAISER, Marcel</creator><creator>BRUN, Reto</creator><creator>RUIZ-PéREZ, Luis M.</creator><creator>SAHLBERG, Britt-Louise</creator><creator>JOHANSSON, Nils Gunnar</creator><creator>GONZáLEZ-PACANOWSKA, Dolores</creator><creator>GILBERT, Ian H.</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20060713</creationdate><title>Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase</title><author>NGUYEN, Corinne ; RUDA, Gian Filippo ; SCHIPANI, Alessandro ; KASINATHAN, Ganasan ; LEAL, Isabel ; MUSSO-BUENDIA, Alexander ; KAISER, Marcel ; BRUN, Reto ; RUIZ-PéREZ, Luis M. ; SAHLBERG, Britt-Louise ; JOHANSSON, Nils Gunnar ; GONZáLEZ-PACANOWSKA, Dolores ; GILBERT, Ian H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i277t-45c465835ca3398dff711bf6e9473bc58e96e8053a70ed6f25b71476e590a6653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials - chemical synthesis</topic><topic>Antimalarials - pharmacology</topic><topic>Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Erythrocytes - drug effects</topic><topic>Erythrocytes - parasitology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Nucleosides - chemical synthesis</topic><topic>Nucleosides - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasmodium falciparum - drug effects</topic><topic>Plasmodium falciparum - enzymology</topic><topic>Pyrophosphatases - antagonists &amp; inhibitors</topic><topic>Pyrophosphatases - chemistry</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Trityl Compounds - chemical synthesis</topic><topic>Trityl Compounds - pharmacology</topic><topic>Uracil - analogs &amp; derivatives</topic><topic>Uracil - chemical synthesis</topic><topic>Uracil - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NGUYEN, Corinne</creatorcontrib><creatorcontrib>RUDA, Gian Filippo</creatorcontrib><creatorcontrib>SCHIPANI, Alessandro</creatorcontrib><creatorcontrib>KASINATHAN, Ganasan</creatorcontrib><creatorcontrib>LEAL, Isabel</creatorcontrib><creatorcontrib>MUSSO-BUENDIA, Alexander</creatorcontrib><creatorcontrib>KAISER, Marcel</creatorcontrib><creatorcontrib>BRUN, Reto</creatorcontrib><creatorcontrib>RUIZ-PéREZ, Luis M.</creatorcontrib><creatorcontrib>SAHLBERG, Britt-Louise</creatorcontrib><creatorcontrib>JOHANSSON, Nils Gunnar</creatorcontrib><creatorcontrib>GONZáLEZ-PACANOWSKA, Dolores</creatorcontrib><creatorcontrib>GILBERT, Ian H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NGUYEN, Corinne</au><au>RUDA, Gian Filippo</au><au>SCHIPANI, Alessandro</au><au>KASINATHAN, Ganasan</au><au>LEAL, Isabel</au><au>MUSSO-BUENDIA, Alexander</au><au>KAISER, Marcel</au><au>BRUN, Reto</au><au>RUIZ-PéREZ, Luis M.</au><au>SAHLBERG, Britt-Louise</au><au>JOHANSSON, Nils Gunnar</au><au>GONZáLEZ-PACANOWSKA, Dolores</au><au>GILBERT, Ian H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2006-07-13</date><risdate>2006</risdate><volume>49</volume><issue>14</issue><spage>4183</spage><epage>4195</epage><pages>4183-4195</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>We report the discovery of novel uracil-based acyclic compounds as inhibitors of deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase), an enzyme involved in nucleotide metabolism that has been identified as a promising target for the development of antimalarial drugs. Compounds were assayed against both P.falciparum dUTPase and intact parasites. A good correlation was observed between enzyme inhibition and cellular assays. Acyclic uracil derivatives were identified that showed greater or similar potency and in general increased selectivity compared to previously reported inhibitors. The most active compound reported here against the P. falciparum enzyme had a K(i) of 0.2 microM. Molecular modeling studies provided a good rationale for the observed activities. Preliminary ADME studies indicated that some of the lead compounds are drug-like molecules. These compounds are useful tools for further investigating P. falciparum dUTPase for the development of much-needed novel antimalarial drugs.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>16821778</pmid><doi>10.1021/jm060126s</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2006-07, Vol.49 (14), p.4183-4195
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_68608803
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antimalarials - chemical synthesis
Antimalarials - pharmacology
Antiparasitic agents
Biological and medical sciences
Erythrocytes - drug effects
Erythrocytes - parasitology
Humans
In Vitro Techniques
Medical sciences
Models, Molecular
Nucleosides - chemical synthesis
Nucleosides - pharmacology
Pharmacology. Drug treatments
Plasmodium falciparum - drug effects
Plasmodium falciparum - enzymology
Pyrophosphatases - antagonists & inhibitors
Pyrophosphatases - chemistry
Stereoisomerism
Structure-Activity Relationship
Trityl Compounds - chemical synthesis
Trityl Compounds - pharmacology
Uracil - analogs & derivatives
Uracil - chemical synthesis
Uracil - pharmacology
title Acyclic Nucleoside Analogues as Inhibitors of Plasmodium falciparum dUTPase
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A16%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acyclic%20Nucleoside%20Analogues%20as%20Inhibitors%20of%20Plasmodium%20falciparum%20dUTPase&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=NGUYEN,%20Corinne&rft.date=2006-07-13&rft.volume=49&rft.issue=14&rft.spage=4183&rft.epage=4195&rft.pages=4183-4195&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm060126s&rft_dat=%3Cproquest_pubme%3E68608803%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i277t-45c465835ca3398dff711bf6e9473bc58e96e8053a70ed6f25b71476e590a6653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68608803&rft_id=info:pmid/16821778&rfr_iscdi=true